These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 4444759)

  • 21. Potentiation of the central nervous system effects of DOPA by decarboxylase inhibition: possible direct role of this neuroamino acid in brain mechanisms.
    Vazquez AJ; Sabelli HC
    Exp Neurol; 1975 Jan; 46(1):44-56. PubMed ID: 1109342
    [No Abstract]   [Full Text] [Related]  

  • 22. Correlation between brain dopamine levels and 1-dopa activity in anti-Parkinson tests.
    Horst WD; Pool WR; Spiegel HE
    Eur J Pharmacol; 1973 Mar; 21(3):337-42. PubMed ID: 4736076
    [No Abstract]   [Full Text] [Related]  

  • 23. Potentiation and inhbition of some central actions of L(-)-dopa by decarboxylase inhibitors.
    Lotti VJ; Porter CC
    J Pharmacol Exp Ther; 1970 Apr; 172(2):406-15. PubMed ID: 5441162
    [No Abstract]   [Full Text] [Related]  

  • 24. Biochemical and behavioral effects of l-DOPA methyl ester in cats treated with reserpine.
    Hanson LC; Utley JD
    Psychopharmacologia; 1965 Jul; 8(2):140-4. PubMed ID: 5853737
    [No Abstract]   [Full Text] [Related]  

  • 25. Potentiation of the haloperidol-induced blockade of a conditioned avoidance response by alpha-methyltyrosine.
    Monti JM; Ruiz M
    Eur J Pharmacol; 1973 Oct; 24(1):25-8. PubMed ID: 4756166
    [No Abstract]   [Full Text] [Related]  

  • 26. Behavioral and biochemical effects of alpha-methyltyrosine in cats.
    Kitsikis A; Roberge AG
    Psychopharmacologia; 1973 Jul; 31(2):143-55. PubMed ID: 4722207
    [No Abstract]   [Full Text] [Related]  

  • 27. The effects of drugs on the behavioural and biochemical actions of intraventricular 6-hydroxydopamine.
    Taylor KM; Laverty R
    Eur J Pharmacol; 1972 Jan; 17(1):16-24. PubMed ID: 5016577
    [No Abstract]   [Full Text] [Related]  

  • 28. Comparative investigation of inhibitors of extracerebral dopa decarboxylase in man and rats.
    Kuruma I; Bartholini G; Tissot R; Fletscher A
    J Pharm Pharmacol; 1972 Apr; 24(4):289-94. PubMed ID: 4402836
    [No Abstract]   [Full Text] [Related]  

  • 29. Effect of alpha-methyl dopa on the reserpine-induced suppression of motor activity and the conditioned avoidance response.
    Uretsky NJ; Seiden LS
    J Pharmacol Exp Ther; 1969 Jul; 168(1):153-62. PubMed ID: 4307318
    [No Abstract]   [Full Text] [Related]  

  • 30. Antagonism by alpha-methyltyrosine of morphine induced motility in non-tolerant and tolerant rats.
    Davis WM; Babbini M; Khalsa HJ
    Res Commun Chem Pathol Pharmacol; 1972 Sep; 4(2):267-79. PubMed ID: 5074526
    [No Abstract]   [Full Text] [Related]  

  • 31. Some actions of pentazocine on behavior and brain monoamines in the rat.
    Holtzman SG; Jewett RE
    J Pharmacol Exp Ther; 1972 May; 181(2):346-56. PubMed ID: 5030675
    [No Abstract]   [Full Text] [Related]  

  • 32. On the localization of the hypotensive effect of L-dopa.
    Henning M; Rubenson A; Trolin G
    J Pharm Pharmacol; 1972 Jun; 24(6):447-51. PubMed ID: 4403826
    [No Abstract]   [Full Text] [Related]  

  • 33. Inhibition of catecholamine synthesis and conditioned avoidance acquisition.
    Ahlenius S
    Pharmacol Biochem Behav; 1973; 1(3):347-50. PubMed ID: 4775861
    [No Abstract]   [Full Text] [Related]  

  • 34. The induction and antagonism of central nervous system stimulant-induced stereotyped behavior in the cat.
    Wallach MB; Gershon S
    Eur J Pharmacol; 1972 Apr; 18(1):22-6. PubMed ID: 5031271
    [No Abstract]   [Full Text] [Related]  

  • 35. 5-Hydroxytryptophan reversal of reserpine enhancement of audiogenic seizure susceptibility in mice.
    Boggan WO; Seiden LS
    Physiol Behav; 1973 Jan; 10(1):9-12. PubMed ID: 4540511
    [No Abstract]   [Full Text] [Related]  

  • 36. Dopa-induced locomotor stimulation after inhibition of extracerebral decarboxylase.
    Bartholini G; Blum JE; Pletscher A
    J Pharm Pharmacol; 1969 May; 21(5):297-301. PubMed ID: 4390121
    [No Abstract]   [Full Text] [Related]  

  • 37. The effects of reserpine, alpha-methyltyrosine, and L-3,4-dihydroxyphenylalanine on brain tyrosine transaminase.
    Gibb JW; Webb JG
    Proc Natl Acad Sci U S A; 1969 Jun; 63(2):364-9. PubMed ID: 4389816
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An analysis of DOPA-induced locomotor stimulation in mice with inhibited extracerebral decarboxylase.
    Przegaliński E; Kleinrok Z
    Psychopharmacologia; 1972; 23(3):279-88. PubMed ID: 4260342
    [No Abstract]   [Full Text] [Related]  

  • 39. Comparison of the effectiveness of deserpidine, reserpine, and alpha-methyltyrosine on brain biogenic amines.
    Fulton SC; Healy MD
    Fed Proc; 1976 Dec; 35(14):2558-62. PubMed ID: 11134
    [No Abstract]   [Full Text] [Related]  

  • 40. L-DOPA induced effects on motor activity in mice after inhibition of dopamine-beta-hydroxylase.
    Strömberg U; Svensson TH
    Psychopharmacologia; 1971; 19(1):53-60. PubMed ID: 5089105
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.